Link You & Key Solution
Lynk Coating is designed
to solve surgical complications
Lynk Coating can be applied to a variety of medical devices with different materials,
providing solutions that enhances the safety and precision of surgeries
in a wide range of fields for both medical professionals and patients.
PUBLICATIONS
NEWS
Jungmok Seo, CEO of LynkSolutec (pictured right), poses for a commemorative photo with Ki-yong Song, Managing Director of Moneytoday, after receiving the ‘R&D Innovation Grand Prize’ in the ‘Medical Device Coating Technology’ category at the ‘2024 10th Korea Business Awards’ ceremony hosted by Money Today. The event was held at the Korea Press Center in Jung-gu, Seoul, on the afternoon of the 20th.
LynkSolutec is a startup that developed ‘Lynk Coating,’ a medical coating technology that addresses complications such as infection, inflammation, and thrombosis during surgery. The company is a spin-off from Yonsei University’s BioLogical Interfaces and Sensor Systems Laboratory. A company representative stated, “We won two Innovation Awards at the 2024 Consumer Electronics Show (CES),” adding, “We will present a new paradigm that minimizes side effects of implantable medical devices.”
- 2024-12-20
- Moneytoday
Lynk Solutec, a medical device surface coating technology company led by CEO Jungmok Seo, has announced the acquisition of two innovative coating technology patents that can significantly enhance safety in medical settings. The newly registered patents are for “Medical Implant Coating Composition for Foreign Material Prevention” and “Suture Coating Composition for Foreign Material Prevention.”
The core of these newly developed coating technologies lies in their special composition that fundamentally prevents the adhesion of all foreign materials, including blood, moisture, mucus, and bacteria. CTO Yeonteak Lee explained, “Medical implants and sutures come into contact with various foreign substances within the body, such as blood, mucus, bacteria, cells, and calcification. The adhesion of these substances can cause serious side effects, including infections, inflammation, and thrombosis formation. These patent technologies provide an innovative solution that fundamentally addresses these issues.”
The implant coating technology can be applied to a wide range of medical devices, including various types of stents for the esophagus, blood vessels, bile duct, gallbladder, pancreas, uterus, urethra, and ureter, as well as drainage catheters, injection catheters, parenteral catheters, and urological catheters. The suture coating technology is applicable to all types of sutures, including dental/ophthalmic and microsurgical sutures. Notably, unlike existing coating technologies, these new innovations allow for additional lubricant coating on top of the coated medical devices, further enhancing their performance.
CEO Jungmok Seo emphasized, “These patent technologies can dramatically reduce medical device-related complications. In particular, they can significantly improve the safety and accuracy of surgical procedures by minimizing the risks of infection, inflammation, and thrombosis formation.” He also added, “We are currently preparing for clinical trials to commercialize these patent technologies and plan to complete product development in the near future.”
Lynk Solutec, a spin-off company from the BioLogical Interfaces and Sensor Systems Laboratory at Yonsei University, continues to drive innovation in medical settings through its medical device coating technologies.
- 2024-11-15
Lynk Solutec, a medical device surface coating company led by CEO Jungmok Seo, announced on the 17th that it has recently obtained a patent for an ‘endoscope coating.’
The official title of this patent is ‘Coating Composition for Endoscope Protection.’ This coating composition, when applied to an endoscope, prevents the adhesion of biological substances like blood and fogging. It can protect the surface of the endoscope’s distal end, such as the lens and cap, in the form of a coating or film.
Endoscopes are medical instruments used with cameras to observe and diagnose the inside of a patient’s body before, during, and after surgery in various medical fields. The company emphasized, “Maintaining a clear view during endoscopic procedures is directly linked to the success of the surgery, which makes continuous research and improvement essential.” They further explained, “Currently, doctors must manually clean the lenses or frequently apply anti-fog agents. This process extends surgery time by approximately 20%, increasing medical staff fatigue and the risk of patient infection during endoscope re-insertion.”
Jungmok Seo, CEO of Lynk Solutec, said, “This patented technology is a special coating that fundamentally prevents the adhesion of blood, moisture, mucus, and bacteria. By applying a coating layer on the endoscope cap or distal end, it ensures a clearer view.” He added, “We expect this technology to be widely applicable in various endoscopic fields, including gastrointestinal endoscopy, laparoscopy, bronchoscopy, and surgical robots.”
Lynk Solutec is a spin-off from BioLogical Interface and Sensor System Lab at Yonsei University. The company has developed medical coating technology called ‘Lynk Coating,’ which addresses complications such as infections, inflammation, and thrombus formation during surgery. With this technology, they have introduced innovative medical devices, including endoscope caps that help secure visibility during endoscopic surgeries and ureteral stents that prevent calcification.
- 2024-10-17
- MoneyToday
Jung-mok Seo, CEO of Lynk Solutec, a company developing innovative medical devices based on medical device coating technology, was invited as a speaker at the 2024 Yonsei University Laboratory Startup Conference.
During the event, CEO Seo presented successful cases of technology startups as a professor in the Department of Electrical and Electronic Engineering. Leading the Yonsei University BioLogical Interface and Sensor Systems Laboratory, he developed a coating technology that can fundamentally inhibit infection, inflammation, and thrombosis for the first time in the world. He shared vibrant examples of how he is expanding his business by showcasing innovative medical devices such as “an endoscopic cap that provides a clear surgical view” and “a ureteral stent that inhibits calcification”
In the following “Laboratory Startup Talk Concert,” he participated in a panel discussion with the Yonsei University Startup Support Team. CEO Seo shared insights on the development direction and challenges of the laboratory startup ecosystem, drawing significant interest from the audience.
- 2024-09-12
